QQ客服 官方微博 反馈留言

	CRISPR/Cas9-mediated hypoxia inducible factor-1 alpha knockout enhances the antitumor effect of transarterial embolization in hepatocellular carcinoma
	Liu, Quan[1,2]; Fan, Dahua[3]; Adah, Dickson[4,5]; Wu, Zhengzhi[3]; Liu, Renyan[6]; Yan, Qiao-Ting[1]; Zhang, Yue[1]; Du, Zhi-Yong[1]; Wang, Dou[1,2]; Li, Yan[1]
	2018
卷号	40期号:5页码:2547
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4773633
专题	暨南大学
作者单位	1.[1]Jinan Univ, Clin Med Coll 2, Shenzhen Peoples Hosp, Dept Hepatobiliary & Pancreas Surg, 1017 Dongmen North Rd, Shenzhen 518020, Guangdong, Peoples R China 2.[2]Jinan Univ, Integrated Chinese & Western Med Postdoctoral Res, Guangzhou 510632, Guangdong, Peoples R China 3.[3]Sun Yat Sen Univ, Affiliated Hosp 8, Dept Chinese & Western Integrat Med, Shenzhen 518033, Guangdong, Peoples R China 4.[4]Univ Chinese Acad Sci, Beijing 100049, Peoples R China 5.[5]Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Dept Infect & Immun, State Key Lab Resp Dis, Guangzhou 510530, Guangdong, Peoples R China 6.[6]SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA
推荐引用方式 GB/T 7714	Liu, Quan[1,2],Fan, Dahua[3],Adah, Dickson[4,5],et al. CRISPR/Cas9-mediated hypoxia inducible factor-1 alpha knockout enhances the antitumor effect of transarterial embolization in hepatocellular carcinoma[J],2018,40(5):2547.
APA	Liu, Quan[1,2].,Fan, Dahua[3].,Adah, Dickson[4,5].,Wu, Zhengzhi[3].,Liu, Renyan[6].,...&Liu, Li-Ping[1].(2018).CRISPR/Cas9-mediated hypoxia inducible factor-1 alpha knockout enhances the antitumor effect of transarterial embolization in hepatocellular carcinoma.,40(5),2547.
MLA	Liu, Quan[1,2],et al."CRISPR/Cas9-mediated hypoxia inducible factor-1 alpha knockout enhances the antitumor effect of transarterial embolization in hepatocellular carcinoma".40.5(2018):2547.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。